Holly Baldwin
Independent Consultant, Oxford University Innovation

Holly Ann Baldwin is the CEO Designate for a potential spin out organisation from Oxford University. Academic teams have developed two unique digital platforms for better engagement, recruitment and consent practices in the life science and clinical trial marketplace.

Holly started her career in the medicine in the US Army and specialised in cardiac diseases and transplant.  After 10+ years in patient care, academics and clinical trials, she transitioned to medical device companies (Medtronic & HeartWare). Holly spent 11 years in commercial roles within sales, clinical trials, quality, and manufacturing; including high profile projects supporting a company exit of $1B in 2016.

Holly attended Rutgers University (BSc), Seton Hall University (MSc) and Henley Business School (MBA).

Holly’s primary goal is to take the two market ready products and transform the clinical trial space with ethical digital technologies focused on data-sharing frameworks, governance and best practice. She seeks to raise £1M to spin out from Oxford University, hire talent to deliver to eagerly waiting customers.

What's On

More speakers

Barbara Ghinelli

Barbara Ghinelli

Director, Clusters and Harwell Campus Business Development, UKRI-STFC

Henry Snaith

Henry Snaith

Co-founder and Chief Scientific Offer, Oxford PV

Tim Curtis

Tim Curtis

Managing Director, Ricardo Energy & Environment

Stuart Woods

Stuart Woods

Managing Director, Oxford Instruments NanoScience

 

PARTNERS

Visit Britain

Keep in touch

Sign up to the Venturefest Oxford newsletter to make sure you are the first to hear the latest news. The next #vfestox newsletter will be coming out soon! Make sure you're on the list!

 

 

 

 

 

Email Preferences

Make connections that lead to new investments, new businesses and new ideas in the high-tech sector in Oxfordshire.